Skip to main content
. 2020 Jun 4;11:422. doi: 10.3389/fneur.2020.00422

Table 2.

Transcranial magnetic stimulation values between stronger and weaker sides.

Median (range) Pre training Post training 3-month follow up
TMS variable Stronger Weaker Sig. Stronger Weaker Sig. Stronger Weaker Sig.
RMT (MSO%) 40 (28–68)a 45 (30–73)a 0.618 37 (22–76) 48 (26–92) 0.205 43 (24–56)d 40 (29–81)f 0.138
AMT (MSO%) 33 (20–64) 42 (27–100) 0.058 27 (17–45) 37 (18.76) 0.042* 30 (20–60)e 31 (21–64)f 0.307
MEP105%AMT 231.13 (186.67–331.17) 415.5 (181.5–464.25)b 0.046* 477.18 (243.50–1097.17) 222.50 (124.17–1072.20) 0.012 374.60 (91.50–634.40)e 295.88 (165.33–358.67)f 0.116
MEP115%AMT 310.00 (96.75–1398.00) 593.05 (174.00–1130.00)b 0.463 621.21 (319.00–1422.75) 320.75 (172.75–1720.80) 0.050 430.75 (146.25–1360.50)e 370.42 (153.00–860.33)f 0.600
MEP125%AMT 344.92 (199.50–2640.00) 818.47 (161.00–1365.77)b 0.753 740.50 (209.47–1592.00) 510–13 (226.60–3030.33) 0.779 597.40 (213.20–2100.00)e 772.17 (228.67–1453.75)f 0.753
MEP135%AMT 672.58 (248.00–3546.00) 550.23 (206.00–1483.67)b 0.345 1348.75 (353.33–1722.25) 665.50 (237.75–3587.33)c 0.237 724.20 (117.00–4664.40)e 994.67 (232.67–2159.67)f 0.463
MEP145%AMT 568.00 (334.50–3727.80) 564.63 (248.00–1812.67)b 0.345 1784.88 (430.33–4608.00) 765.67 (310.50–3998.00)c 0.128 1065.67 (272.00–4634.00)e 1165.08 (260.33–2814.80)f 0.345
MEP155%AMT 1037.55 (357.00–3771.33) 870.67 (468.50–1933.00)b 0.686 2047.85 (373.75–4031.20) 892.50 (232.33–4268.00)c 0.091 1346.17 (98.00–4669.00)e 1252.75 (257.20–2798.00)f 0.249
eREC slope (gain) 14.80 (3.53–77.38) 3.14 (−1.83–30.00)b 0.075 28.41 (3.22–82.06) 10.18 (1.70–66.77)c 0.091 15.51 (0.90–49.28)e 19.11 (2.24–59.03)f 0.686
eREC R2 (accuracy) 0.77 (0.51–0.97) 0.35 (0.00–0.97)b 0.173 0.76 (.042–0.96) 0.82 (0.66–0.99)c 0.499 0.78 (0.05–0.87)e 0.91 (0.82–0.95)f 0.043*
eREC AUC (overall excitation) 25852 (13182–126385) 30498 (7558–65129)b 0.463 58744.17 (16940.42–108246.00) 30189.83 (11258.50–150065.17)c 0.176 34050.50 (8432.00–154112.00)e 40965.42 (10859.33–83448.00)f 0.463
CSP105%AMT 89.56 (34.65–177.40) 72.47 (50.61–249.76)b 0.249 33.35 (16.17–91.63) 82.77 (31.92–279.04) 0.012* 49.66 (32.80–269.32)e 75.26 (37.17–229.93)f 0.249
CSP115%AMT 118.31 (45.06–181.49) 102.27 (84.86–266.75)b 0.345 62.34 (19.35–219.98) 112.16 (40.96–271.27) 0.036* 98.03 (18.88–279.07)e 108.28 (55.22–229.40)f 0.046*
CSP125%AMT 138.49 (58.90–233.98) 128.85 (101.84–255.44)b 0.116 71.41 (44.46–190.77) 148.58 (52.44–307.23) 0.017* 124.91 (45.60–186.06)e 169.13 (87.86–259.93)f 0.046*
CSP135%AMT 151.60 (67.87–237.88) 150.01 (121.46–272.03)b 0.345 83.57 (40.51–201.44) 140.24 (73.29–292.23)c 0.018* 142.76 (47.85–304.16)e 170.69 (77.56–225.96)f 0.173
CSP145%AMT 157.33 (82.26–282.32) 151.81 (139.38–325.93)b 0.173 137.96 (67.22–238.43) 159.61 (94.94–347.51)c 0.018* 167.32 (123.66–316.11)e 175.15 (83.65–252.69)f 0.345
CSP155%AMT 174.75 (101.28–294.92) 158.33 (146.92–187.09)b 0.893 143.82 (66.13–257.88) 156.08 (129.73–233.08)c 0.028* 156.71 (121.33–179.94)e 169.94 (149.51–293.69)f 0.046*
iREC slope (Gain) 1.88 (0.91–3.68) 1.84 (0.83–2.19)b 0.893 2.04 (0.89–2.56) 1.97 (0.29–2.88)c 0.866 2.17 (0.75–2.73)e 1.76 (1.03–2.27)f 0.345
iREC R2 (accuracy) 0.94 (0.75–0.99) 0.88 (0.84–0.99)b 0.893 0.88 (0.67–0.97) 0.87 (0.01–0.95)c 0.237 0.90 (0.73–0.93)e 0.70 (0.54–0.79)f 0.028*
iREC AUC (overall Inhibition) 6975.5 (3262.0–11718.0) 6531.5 (5823.00–12450.30)b 0.249 4369.13 (2271.20–10254.75) 6666.25 (3601.05–13043.85)c 0.018* 5857.20 (3397.85–7825.15)e 7482.20 (3976.30–12292.90)f 0.116
MEP latency (ms) 24.17 (21.38–43.15)a 26.26 (20.45–35.52)a 0.866 24.51 (19.48–43.78) 25.95 (20.36–38.02) 1.000 22.12 (21.88–29.69)e 25.97 (20.26–28.20)f 0.686

AMT, active motor threshold; CSP, cortical silent period; eREC, excitatory recruitment curve; iREC, inhibitory recruitment curve; MEP, motor evoked potential; MSO%, maximal stimulator output percentage; RMT, resting motor threshold; eREC Slope = MEP Amplitude (μV) by TMS intensity105−155%AMT; iREC Slope = CSP time (ms) by TMS intensity105−155%AMT; Area under the curve (AUC) was calculated for both excitatory and inhibitory RECs using the trapezoid rule ΔX x (Y1+Y2)/2, whereby X were the MSO% used (i.e., X axis values, 105–155% of AMT) and Y are the recorded CSP lengths (ms) or the MEP amplitudes (μV).

*

Difference between stronger and weaker hand is statistically significant at α <0.05.

a

Missing data from participant 2 due to too low corticospinal excitability (i.e., no resting MEPs).

b

Missing data from participant 2 and 7 due to too high AMT (AMT = 100 and 82%, respectively), thus the required increases in MSO% based on AMT to assess the REC could not be performed).

c

Missing data from participant 7 due to high AMT (AMT = 76%), thus the required intensities of 135–155% of AMT could not be performed, and the slope, R2 and AUC could not be calculated).

d

Time point with n = 5 (participant 2 could not be reached during follow-up assessment, missing data from participant 7 and 6 due to too low corticospinal excitability (i.e., no resting MEPs) and overheating of equipment (i.e., stimulator).

e

Missing data from participant 2 (could not be reached during follow-up).

f

Missing data from participant 2 (could not be reached during follow-up) and 7 [too low corticospinal excitability (i.e., no resting or contracting MEPs (RMT and AMT)].